349 related articles for article (PubMed ID: 36674870)
1. Emerging Perspectives on the Antiparasitic Mebendazole as a Repurposed Drug for the Treatment of Brain Cancers.
Meco D; Attinà G; Mastrangelo S; Navarra P; Ruggiero A
Int J Mol Sci; 2023 Jan; 24(2):. PubMed ID: 36674870
[TBL] [Abstract][Full Text] [Related]
2. Antiparasitic mebendazole (MBZ) effectively overcomes cisplatin resistance in human ovarian cancer cells by inhibiting multiple cancer-associated signaling pathways.
Huang L; Zhao L; Zhang J; He F; Wang H; Liu Q; Shi D; Ni N; Wagstaff W; Chen C; Reid RR; Haydon RC; Luu HH; Shen L; He TC; Tang L
Aging (Albany NY); 2021 Jul; 13(13):17407-17427. PubMed ID: 34232919
[TBL] [Abstract][Full Text] [Related]
3. Anthelmintic mebendazole enhances cisplatin's effect on suppressing cell proliferation and promotes differentiation of head and neck squamous cell carcinoma (HNSCC).
Zhang F; Li Y; Zhang H; Huang E; Gao L; Luo W; Wei Q; Fan J; Song D; Liao J; Zou Y; Liu F; Liu J; Huang J; Guo D; Ma C; Hu X; Li L; Qu X; Chen L; Yu X; Zhang Z; Wu T; Luu HH; Haydon RC; Song J; He TC; Ji P
Oncotarget; 2017 Feb; 8(8):12968-12982. PubMed ID: 28099902
[TBL] [Abstract][Full Text] [Related]
4. Repurposing Mebendazole as a Replacement for Vincristine for the Treatment of Brain Tumors.
De Witt M; Gamble A; Hanson D; Markowitz D; Powell C; Al Dimassi S; Atlas M; Boockvar J; Ruggieri R; Symons M
Mol Med; 2017 Apr; 23():50-56. PubMed ID: 28386621
[TBL] [Abstract][Full Text] [Related]
5. Mebendazole prevents distant organ metastases in part by decreasing ITGβ4 expression and cancer stemness.
Joe NS; Godet I; Milki N; Ain NUI; Oza HH; Riggins GJ; Gilkes DM
Breast Cancer Res; 2022 Dec; 24(1):98. PubMed ID: 36578038
[TBL] [Abstract][Full Text] [Related]
6. The Antitumor Potentials of Benzimidazole Anthelmintics as Repurposing Drugs.
Son DS; Lee ES; Adunyah SE
Immune Netw; 2020 Aug; 20(4):e29. PubMed ID: 32895616
[TBL] [Abstract][Full Text] [Related]
7. Repurposing the antihelmintic mebendazole as a hedgehog inhibitor.
Larsen AR; Bai RY; Chung JH; Borodovsky A; Rudin CM; Riggins GJ; Bunz F
Mol Cancer Ther; 2015 Jan; 14(1):3-13. PubMed ID: 25376612
[TBL] [Abstract][Full Text] [Related]
8. Mebendazole exhibits potent anti-leukemia activity on acute myeloid leukemia.
He L; Shi L; Du Z; Huang H; Gong R; Ma L; Chen L; Gao S; Lyu J; Gu H
Exp Cell Res; 2018 Aug; 369(1):61-68. PubMed ID: 29750898
[TBL] [Abstract][Full Text] [Related]
9. Mebendazole is a potent inhibitor to chemoresistant T cell acute lymphoblastic leukemia cells.
Wang X; Lou K; Song X; Ma H; Zhou X; Xu H; Wang W
Toxicol Appl Pharmacol; 2020 Jun; 396():115001. PubMed ID: 32277947
[TBL] [Abstract][Full Text] [Related]
10. Mebendazole inhibits growth of human adrenocortical carcinoma cell lines implanted in nude mice.
Martarelli D; Pompei P; Baldi C; Mazzoni G
Cancer Chemother Pharmacol; 2008 Apr; 61(5):809-17. PubMed ID: 17581752
[TBL] [Abstract][Full Text] [Related]
11. Mebendazole as a Candidate for Drug Repurposing in Oncology: An Extensive Review of Current Literature.
Guerini AE; Triggiani L; Maddalo M; Bonù ML; Frassine F; Baiguini A; Alghisi A; Tomasini D; Borghetti P; Pasinetti N; Bresciani R; Magrini SM; Buglione M
Cancers (Basel); 2019 Aug; 11(9):. PubMed ID: 31480477
[TBL] [Abstract][Full Text] [Related]
12. Effective treatment of diverse medulloblastoma models with mebendazole and its impact on tumor angiogenesis.
Bai RY; Staedtke V; Rudin CM; Bunz F; Riggins GJ
Neuro Oncol; 2015 Apr; 17(4):545-54. PubMed ID: 25253417
[TBL] [Abstract][Full Text] [Related]
13. Anticancer Effect of Benzimidazole Derivatives, Especially Mebendazole, on Triple-Negative Breast Cancer (TNBC) and Radiotherapy-Resistant TNBC In Vivo and In Vitro.
Choi HS; Ko YS; Jin H; Kang KM; Ha IB; Jeong H; Song HN; Kim HJ; Jeong BK
Molecules; 2021 Aug; 26(17):. PubMed ID: 34500557
[TBL] [Abstract][Full Text] [Related]
14. EFFECT OF THE ANTIPARASITIC DRUG MEBENDAZOLE ON CHOLANGIOCARCINOMA GROWTH.
Sawanyawisuth K; Williamson T; Wongkham S; Riggins GJ
Southeast Asian J Trop Med Public Health; 2014 Nov; 45(6):1264-70. PubMed ID: 26466412
[TBL] [Abstract][Full Text] [Related]
15. In vitro and in vivo anticancer activity of mebendazole in colon cancer: a promising drug repositioning.
Aliabadi A; Haghshenas MR; Kiani R; Koohi-Hosseinabadi O; Purkhosrow A; Pirsalami F; Panjehshahin MR; Erfani N
Naunyn Schmiedebergs Arch Pharmacol; 2024 Apr; 397(4):2379-2388. PubMed ID: 37837472
[TBL] [Abstract][Full Text] [Related]
16. Repurposing screen identifies mebendazole as a clinical candidate to synergise with docetaxel for prostate cancer treatment.
Rushworth LK; Hewit K; Munnings-Tomes S; Somani S; James D; Shanks E; Dufès C; Straube A; Patel R; Leung HY
Br J Cancer; 2020 Feb; 122(4):517-527. PubMed ID: 31844184
[TBL] [Abstract][Full Text] [Related]
17. Antiparasitic mebendazole shows survival benefit in 2 preclinical models of glioblastoma multiforme.
Bai RY; Staedtke V; Aprhys CM; Gallia GL; Riggins GJ
Neuro Oncol; 2011 Sep; 13(9):974-82. PubMed ID: 21764822
[TBL] [Abstract][Full Text] [Related]
18. In silico molecular target prediction unveils mebendazole as a potent MAPK14 inhibitor.
Ariey-Bonnet J; Carrasco K; Le Grand M; Hoffer L; Betzi S; Feracci M; Tsvetkov P; Devred F; Collette Y; Morelli X; Ballester P; Pasquier E
Mol Oncol; 2020 Dec; 14(12):3083-3099. PubMed ID: 33021050
[TBL] [Abstract][Full Text] [Related]
19. Repositioning of the anthelmintic drug mebendazole for the treatment for colon cancer.
Nygren P; Fryknäs M; Agerup B; Larsson R
J Cancer Res Clin Oncol; 2013 Dec; 139(12):2133-40. PubMed ID: 24135855
[TBL] [Abstract][Full Text] [Related]
20. Drug Repurposing in Pediatric Brain Tumors: Posterior Fossa Ependymoma and Diffuse Midline Glioma under the Looking Glass.
Servidei T; Sgambato A; Lucchetti D; Navarra P; Ruggiero A
Front Biosci (Landmark Ed); 2023 Apr; 28(4):77. PubMed ID: 37114548
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
